The US healthcare system is fragmented, often making it difficult for patients to access affordable medication. Employers can play an important role in supporting their employees by offering comprehensive pharmacy benefits.
We are excited to partner with Andel from Day One and support the team on their mission to revolutionise access to critical treatments.
Andel’s unique cooperative model leverages members’ combined buying power to purchase medications directly from manufacturers at below-market prices. Employers can add a subsidy of their choosing to reduce costs to members even further.
Andel’s native app provides a seamless experience from prescription verification to next‑day delivery. Employees obtain the brand-name medicine they need at a price they can afford, without having to wait for approvals or prerequisites.
Ritu Malhotra, co-founder of Andel and a licensed pharmacist, highlights:
“Expanding access to healthcare is the cornerstone of our mission. Andel gives employers an innovative new pharmacy benefit solution that fills the coverage gap.”
Jay Bregman, co-founder and CEO, adds:
“We’re living in an era of life-changing medical breakthroughs, yet they remain out of reach for millions of Americans. By building Andel as a cooperative, we align incentives with our members — not insurers.”
Andel’s founding team combines business savvy with a first-hand understanding of the US healthcare ecosystem. Jay Bregman has raised over $250 million and successfully exited three companies, including the ridesharing network Hailo (now Lyft Europe) and Thimble, which was acquired by S&P 500 insurer Arch. Ritu Malhotra brings 20+ years of leadership experience across major benefit consulting firms and served as a top executive at CVS Health.
On why we partnered with Andel, our founder and managing partner, Reshma Sohoni, comments:
“We are incredibly excited to support Andel’s mission of rebuilding the US pharmacy benefits model starting from first principles. Jay and Ritu combine entrepreneurship with in-depth knowledge of the healthcare and pharmacy benefits sector, uniquely positioning them to tackle one of the US healthcare system’s most challenging issues.”
We are thrilled to participate in Andel’s $4.5 million funding round alongside Lightbank, Bertelsmann Investments, Houghton Street Ventures, Springboard, Semper Virens and Citylight.
Andel is launching US-wide in early 2026. To learn more, visit andel.org.